Array BioPharma To Present At The Leerink Swann Global Healthcare Conference - WBOY.com: Clarksburg, Morgantown: News, Sports, Weather

Array BioPharma To Present At The Leerink Swann Global Healthcare Conference

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Array BioPharma Inc.

BOULDER, Colo., Feb. 6, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann Healthcare Conference in New York.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

Event:                    

Leerink Swann Healthcare Conference

Presenter:           

Ron Squarer, Chief Executive Officer

Date:                  

Wednesday, February 12, 2014

Time:               

10:15 a.m. Eastern Time

Location:              

The Waldorf Astoria, New York, NY

Webcast:            

www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520), for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (Novartis).  For more information on Array, please go to www.arraybiopharma.com

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

©2012 PR Newswire. All Rights Reserved.